Why the study?
The efficacy of bupivacaine in supraclavicular block for upper limb surgeries can be influenced by the concomitant administration of additives.
Does adding nalbuphine to bupivacaine improve the duration of analgesia and block characteristics in patients undergoing elective forearm and hand surgeries?
Does adding nalbuphine to bupivacaine improve the duration of analgesia and block characteristics in patients undergoing elective forearm and hand surgeries?
Adding 10 mg of nalbuphine to 0.5% bupivacaine for supraclavicular brachial plexus block significantly prolongs the duration of motor block and postoperative analgesia without increasing adverse effects.
Answers are grounded in this paper and cite their sources.
Supports nalbuphine addition to bupivacaine for supraclavicular blocks in upper extremity surgery; extends RCT evidence on adjuncts for regional analgesia.
Supraclavicular block (SCB) has demonstrated remarkable post-operative patient outcomes in upper limb surgeries. Bupivacaine, a long-acting regional anesthetic, exhibits efficacy that can be influenced by the concomitant administration of additives.
No takes yet. Share an insight, caveat, or question.
Masud et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: